Statements (58)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:biotechnology
|
| gptkbp:business_model |
development and commercialization
|
| gptkbp:can_lead_to |
PH94 B
|
| gptkbp:ceo |
Shawn Singh
|
| gptkbp:clinical_trial |
gptkb:pharmaceuticals
gptkb:AV-101 ongoing studies Phase 1, Phase 2, Phase 3 Phase 2 trials measured in trials analyzed for efficacy conducted in multiple sites PH94 B |
| gptkbp:collaboration |
academic institutions
|
| gptkbp:collaborations |
mental health therapies
with universities |
| gptkbp:collaborative_projects |
with research institutions
|
| gptkbp:community_engagement |
in mental health advocacy
|
| gptkbp:financial_performance |
publicly reported quarterly results
|
| gptkbp:focus |
developing therapies for depression and anxiety
|
| gptkbp:founded |
gptkb:1998
|
| gptkbp:funding |
grants and investments
|
| gptkbp:future_goals |
advancing mental health treatments
|
| gptkbp:has_advisory_board |
experts in neuroscience
|
| gptkbp:headquarters |
gptkb:South_San_Francisco,_California
|
| gptkbp:healthcare |
aims to improve patient outcomes
|
| https://www.w3.org/2000/01/rdf-schema#label |
Vista Gen Therapeutics
|
| gptkbp:instruction_set |
therapeutic candidates
|
| gptkbp:investment |
available online
institutional investors provides updates to shareholders regularly communicated |
| gptkbp:market |
gptkb:United_States
|
| gptkbp:marketing_strategy |
partnerships and collaborations
focused on unmet needs |
| gptkbp:partnership |
pharmaceutical companies
NDA submission with the FDA |
| gptkbp:patient_population |
targeted in studies
|
| gptkbp:publications |
research findings published
|
| gptkbp:regulatory_compliance |
for new therapies
FDA approval process |
| gptkbp:research |
focused on CNS
|
| gptkbp:research_areas |
central nervous system disorders
psychiatric disorders in various stages of development |
| gptkbp:research_focus |
gptkb:depression
anxiety disorders innovative therapies |
| gptkbp:stock_exchange |
gptkb:NASDAQ
|
| gptkbp:stock_symbol |
VTGN
|
| gptkbp:strategic_goals |
expanding product pipeline
|
| gptkbp:target_market |
mental health treatments
|
| gptkbp:team |
experienced professionals
|
| gptkbp:technology |
stem cell technology
|
| gptkbp:treatment |
reported in studies
|
| gptkbp:website |
www.vistagentherapeutics.com
|
| gptkbp:bfsParent |
gptkb:AV-101
|
| gptkbp:bfsLayer |
7
|